DGX today
$259.65+$0.96 (+0.37%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourBullish
1 hourAscending Triangle
15 minBearish
5 minConsolidating
Daily trend turns down below $244.58
Key levels
Support$259.00
Support$250.00
Latest news & SEC filings
SEC FilingQuest Diagnostics Inc filed an insider trading report (Form 4)
NewsQuest Diagnostics board approves a regular quarterly payout to shareholders
NewsJim Davis, Quest Diagnostics chief, put forward for Stryker board seat
All DGX news →About Quest Diagnostics
Quest Diagnostics provides diagnostic testing services through a network of laboratories and patient service centers, primarily in the United States with some international operations. It serves physicians, hospitals, patients, health plans, employers, government agencies, and pharmaceutical companies. The company offers routine and advanced clinical testing, including molecular diagnostics, oncology, neurology, and genetic testing, as well as consumer-initiated tests through its online platform.
Based on the company's 10-K filed Feb 26, 2026.
NYSE · Healthcare
QUEST DIAGNOSTICS INC (DGX)
What Is the Price Target for DGX?
SEPT Low Target
$210.00
SEPT Mid Target
$255.00
SEPT High Target
$260.00
Analyst Consensus
$255.00
Is DGX a Buy or Sell Right Now?
Thesis
- •Revenue growing 11.8% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DGX.
Start Free Trial →Is DGX Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$231.74
32
Moat Score
NONE
6/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with DGX?
Insider Signal
SELLING
0 buys / 8 sells (90d)
Congress Signal
BUYING
5 buys / 6 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Plewman Patrick | officer | Buy | 4,274 | $546K | Nov 9, 2026 |
| Plewman Patrick | officer | Sale | 4,274 | $1.1M | Nov 9, 2026 |
| Plewman Patrick | officer | Buy | 6,793 | $868K | Nov 9, 2026 |
| Plewman Patrick | officer | Sale | 6,793 | $1.7M | Nov 9, 2026 |
| Plewman Patrick | officer | Sale | 650 | $167K | Nov 9, 2026 |
| Ramachandran Subu | officer | Buy | 352 | - | Nov 3, 2026 |
| Doherty Catherine T. | officer | Buy | 4,827 | - | Nov 3, 2026 |
| Doherty Catherine T. | officer | Buy | 22,105 | $2.7M | Nov 3, 2026 |
| Doherty Catherine T. | officer | Sale | 3,818 | $937K | Nov 3, 2026 |
| Doherty Catherine T. | officer | Sale | 5,990 | $1.5M | Nov 3, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →DGX Growth Story
Revenue YoY
11.8%
3yr Revenue CAGR
3.7%
EPS Growth YoY
13.78%
FCF Growth YoY
49.5%
Revenue Trend
ACCELERATING
Dark Pool Trades for DGX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for DGX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:01:50 | $259.65 | 1,333 | $$346K | BUY |
| 21:01:32 | $259.65 | 1,096 | $$285K | BUY |
| 21:01:32 | $259.65 | 15,065 | $$3.9M | BUY |
| 21:01:32 | $259.65 | 2,563 | $$665K | BUY |
| 21:01:32 | $259.65 | 1,544 | $$401K | BUY |
5 dark pool trades shown · $$5.6M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for DGX
PREVIEWSEPT Investing provides real-time options flow tracking for DGX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $270 | Dec 18 | 36 | $$480 | 1 | SWEEP |
| CALL | $270 | Dec 18 | 36 | $$2400 | 5 | SWEEP |
| CALL | $270 | Dec 18 | 36 | $$960 | 2 | SWEEP |
| CALL | $270 | Dec 18 | 36 | $$3360 | 7 | SWEEP |
| CALL | $270 | Dec 18 | 36 | $$480 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for QUEST DIAGNOSTICS INC (DGX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DGX — frequently asked questions
What is DGX stock price today?
QUEST DIAGNOSTICS INC (DGX) is at $259.65, up 0.37% (+$0.96) at the Nov 12, 2026 close.
Why is DGX stock moving today?
Latest DGX news — Nov 12, 2026: Quest Diagnostics Inc filed an insider trading report (Form 4) · Nov 10, 2026: Quest Diagnostics board approves a regular quarterly payout to shareholders
What is the DGX price target?
The average analyst price target for DGX is $255.00, ranging from $210 to $260, based on 7 analysts. Latest: Barclays maintains on Oct 7, 2026.
What do analysts rate DGX?
Analyst ratings for DGX: 0 Buy, 14 Hold, 0 Sell — consensus Hold.
Did DGX beat earnings?
DGX last reported on Oct 22, 2026: EPS $3.00 vs $2.87 expected — a beat of 4.5%.
What is DGX's P/E ratio?
DGX trades at a P/E of 25.9 vs a Healthcare average of 17.4.
Does DGX pay a dividend?
Yes. DGX's dividend yield is 1.83%.
How much debt does DGX have?
QUEST DIAGNOSTICS INC reported $5.5B of debt and $797M of cash (Sep 30, 2026).
What are DGX support and resistance levels?
Support: $259.00, $250.00, $238.62.
What are insiders doing with DGX?
Insider activity: SELLING, 0 buys and 8 sells in the last 90 days.
What is the latest news on DGX?
Nov 12, 2026: Quest Diagnostics Inc filed an insider trading report (Form 4) · Nov 10, 2026: Quest Diagnostics board approves a regular quarterly payout to shareholders · Nov 9, 2026: Jim Davis, Quest Diagnostics chief, put forward for Stryker board seat